RAPT

RAPT Therapeutics Inc
17.45
-0.59 (-3.27%)
Company Name Stock Ticker Symbol Market Type
RAPT Therapeutics Inc RAPT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.59 -3.27% 17.45 20:00:00
Open Price Low Price High Price Close Price Prev Close
17.82 17.19 17.82 17.45 18.04
more quote information »

Recent News

Date Time Source Heading
3/14/202316:06EDGARSecurities Registration: Employee Benefit Plan (s-8)
3/14/202308:06EDGARCurrent Report Filing (8-k)
3/14/202308:03EDGARAnnual Report (10-k)
3/14/202308:00GLOBERAPT Therapeutics Reports Fourth Quarter And Year End..
3/10/202316:53EDGARCurrent Report Filing (8-k)
2/14/202316:40EDGARAmended Statement of Ownership (sc 13g/a)
2/14/202314:33EDGARAmended Statement of Ownership (sc 13g/a)
2/14/202312:43EDGARAmended Statement of Ownership (sc 13g/a)
2/10/202311:41EDGARStatement of Ownership (sc 13g)
2/10/202309:10EDGARAmended Statement of Ownership (sc 13g/a)
2/09/202312:33EDGARAmended Statement of Ownership (sc 13g/a)
2/07/202308:00GLOBERAPT Therapeutics to Participate in the SVB Securities..
2/02/202318:24EDGARStatement of Changes in Beneficial Ownership (4)
2/02/202318:22EDGARStatement of Changes in Beneficial Ownership (4)
2/02/202318:13EDGARStatement of Changes in Beneficial Ownership (4)
2/02/202318:09EDGARStatement of Changes in Beneficial Ownership (4)
1/26/202314:30EDGARStatement of Changes in Beneficial Ownership (4)
1/20/202318:34EDGARStatement of Changes in Beneficial Ownership (4)
1/17/202316:11EDGARStatement of Changes in Beneficial Ownership (4)
1/09/202308:04EDGARCurrent Report Filing (8-k)
1/03/202308:00GLOBERAPT Therapeutics to Present at the 41st Annual J.P. Morgan..
12/12/202216:03EDGARCurrent Report Filing (8-k)
12/12/202206:35TRMNSVB Securities Keeps Their Buy Rating on RAPT Therapeutics..
12/08/202206:30GLOBERAPT Therapeutics Presents Update from its Phase 1/2..
11/30/202219:05GLOBERAPT Therapeutics to Present FLX475 Phase 1/2 Data at the..
11/18/202216:53EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
11/18/202206:39TRMNRAPT Therapeutics Tanks on $75M Public Offering
11/17/202221:38GLOBERAPT Therapeutics Announces Pricing of Public Offering of..
11/17/202216:24GLOBERAPT Therapeutics Announces Proposed Public Offering of..
11/13/202222:55TRMNSVB Securities Keeps Their Buy Rating on RAPT Therapeutics..
11/10/202208:22EDGARQuarterly Report (10-q)
11/10/202208:13EDGARCurrent Report Filing (8-k)
11/10/202208:00GLOBERAPT Therapeutics Reports Third Quarter 2022 Financial..
11/09/202208:00GLOBERAPT Therapeutics to Participate in Several Upcoming..
11/03/202218:45EDGARStatement of Changes in Beneficial Ownership (4)
10/04/202212:48EDGARStatement of Changes in Beneficial Ownership (4)
9/28/202208:00GLOBERAPT Therapeutics Strengthens Leadership Team with Two New..
9/06/202219:55EDGARStatement of Changes in Beneficial Ownership (4)
9/06/202216:22EDGARCurrent Report Filing (8-k)
8/31/202208:00GLOBERAPT Therapeutics to Participate in Several Upcoming..
8/11/202216:35TRMNRAPT Therapeutics (RAPT) Receives a Buy from SVB Securities
8/11/202216:30TRMNAnalysts Offer Insights on Healthcare Companies: Abeona..
8/11/202208:22EDGARQuarterly Report (10-q)
8/11/202208:11EDGARCurrent Report Filing (8-k)
8/11/202208:00GLOBERAPT Therapeutics Reports Second Quarter 2022 Financial..
7/26/202223:30TRMNSVB Securities Sticks to Its Buy Rating for RAPT..
6/30/202206:05EDGARNotice of Effectiveness (effect)
6/24/202208:42EDGARSecurities Registration Statement (simplified Form) (s-3)
6/23/202206:25TRMNH.C. Wainwright Sticks to Their Buy Rating for RAPT..
6/03/202217:17EDGARStatement of Ownership (sc 13g)